AS LVP 20D 3SS CV
Report
- Report Number
- 2243072-2021-01617
- Event Type
- Malfunction
- Date Received
- June 4, 2021
- Date of Event
- May 7, 2021
- Report Date
- August 31, 2021
- Product Code
- FPA
- PMA / PMN Number
- K944320
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IL, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE FOLLOWING FIELDS HAVE BEEN UPDATED WITH ADDITIONAL INFORMATION: SITE LEGAL NAME (FDA): TIJUANA B.5. DESCRIBE EVENT OR PROBLEM: THE EVENT DESCRIPTION HAS BEEN UPDATED WITH A NEW MEDICAL DEVICE BRAND NAME. D.1. MEDICAL DEVICE BRAND NAME: AS LVP 20D 3SS CV D.3. MEDICAL DEVICE MANUFACTURER: TIJUANA D.2. MEDICAL DEVICE CATALOG #: 2426-0007 D.4. UNIQUE IDENTIFIER (UDI) #: (B)(4). G.1. MANUFACTURING LOCATION: TIJUANA. G.5. PMA/510(K)#: K944320.
THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D10: DEVICE AVAILABLE FOR EVAL YES, D10: RETURNED TO MANUFACTURER ON: 2021-05-24 H6: INVESTIGATION SUMMARY ONE SAMPLE WAS RETURNED FOR INVESTIGATION BY THE CUSTOMER. THE SAMPLE WAS INVESTIGATION AND FOUND THAT THE PROBABLE CAUSE OF THE CUSTOMER¿S PERCEPTION OF AN OVER INFUSION WAS BELIEVED TO BE DUE TO THE DISPOSABLE SET BACKFLOW FROM THE SECONDARY TO THE PRIMARY IV BAG. A QUALITY NOTIFICATION HAS BEEN SENT TO THE SUPPLIER, AND THE SAMPLE HAS BEEN SENT FOR FURTHER INVESTIGATION. THE SUPPLIER DETERMINED THE ROOT CAUSE TO BE PARTICULATE MATTER FOUND IN THE DEVICE. A DEVICE HISTORY RECORD REVIEW COULD NOT BE PERFORMED BECAUSE A LOT NUMBER WAS NOT PROVIDED BY THE CUSTOMER. THIS INCIDENT HAS BEEN ADDED TO OUR DATABASE OF REPORTED INCIDENTS. OUR BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS. H3 OTHER TEXT : SEE H10
IT WAS REPORTED THAT THERE WAS OVERINFUSION WHILE USING AS LVP 20D 3SS CV. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED THAT THERE IS AN OVER-INFUSION CONCERN.
IT WAS REPORTED THAT THERE WAS OVERINFUSION WHILE USING AS LVP 20D 3SS CV. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED THAT THERE IS AN OVER-INFUSION CONCERN.
DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. UNKNOWN MANUFACTURER: THERE ARE MULTIPLE BD LOCATIONS WHERE THIS UNSPECIFIED BD DEVICE MAY HAVE BEEN MANUFACTURED. A CATALOG AND LOT NUMBER COULD NOT BE CONFIRMED FOR THIS INCIDENT AND WITHOUT THIS INFORMATION WE ARE UNABLE TO DETERMINE WHERE THE DEVICE WAS MANUFACTURED. THEREFORE, BD CORPORATE HEADQUARTERS IN (B)(4) HAS BEEN LISTED AND THE (B)(4) FDA REGISTRATION NUMBER HAS BEEN USED FOR THE MANUFACTURE REPORT NUMBER. MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED. DEVICE MANUFACTURE DATE: UNKNOWN.
IT WAS REPORTED THAT THERE WAS OVERINFUSION WHILE USING UNSPECIFIED BD¿ TUBING. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED THAT THERE IS AN OVER-INFUSION CONCERN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 838791 | AS LVP 20D 3SS CV | INTRAVASCULAR ADMINISTRATION SET | FPA | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |